David Ebersman is the new head of finance at social-networking site Facebook. Ebersman, formerly executive vice president and CFO at Genentech, will start at his new position in September.
Hosted document-management company eGistics Inc. has appointed Timothy Kick to head the finance function. Kick comes to the firm from EDS, where he was CFO of the Financial Services Industry Group.
Randy Furr has been named CFO of Spansion Inc., a provider of Flash memory solutions. Previously, he worked at Sanmina-SCI for 13 years: 4 as CFO, and 9 as president and chief operating officer.
Timothy Krist is the new CFO at jewel manufacturer Charles & Colvard Ltd. He formerly headed finance at Smart Online Inc.
Clearinghouse-services provider NeuStar Inc. has promoted Paul Lalljie to the roles of CFO and treasurer. Lalljie, who has been with the company since 2000, was named interim CFO in January.
Martin Gausvik has resigned as CFO of radio broadcaster Cumulus Media Inc. to pursue other opportunities. Controller J.P. Hannan will head up finance until a permanent replacement is found.
QL2 Software Inc. has named Phil Sabin to lead its finance function. He is a former vice president of finance at Revenue Science.
Payment processor Century Payments Inc. has named Christian Fadel as its new finance chief. Previously, he was CFO of Sage Payment Solutions.
Robert Cuthbert has resigned as CFO and assistant secretary of SeaBright Insurance Holdings Inc. to pursue other opportunities. The company has begun a search for his replacement, and principal accounting officer Philip Romney will be acting principal financial officer until a permanent successor is found.
Aspen Technology Inc. has appointed Mark Sullivan as its CFO. Sullivan worked in financial leadership roles at Fidelity Investments for 14 years, including 7 as CFO of Fidelity Employer Services Co.
Ian Howes is the new CFO and vice president, corporate development, at AkebiaTherapeutics Inc. He comes to the company from Serenex Inc., where he was CFO and senior vice president, corporate development, prior to its sale to Pfizer Inc.